financetom
Business
financetom
/
Business
/
What's Going On With Novavax Stock Thursday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Novavax Stock Thursday?
Jun 6, 2024 6:54 AM

Novavax Inc ( NVAX ) shares are trading higher Thursday after the U.S. Food and Drug Administration's advisory committee voted to recommend updated vaccines for JN.1-lineage of COVID-19.

What To Know: The FDA’s committee of independent advisors voted unanimously on Wednesday to recommend that the FDA tell vaccine makers to update their COVID-19 shots to make them more effective against the JN.1 variants, per CNN.

All 16 advisors reportedly voted “yes” when asked if they recommend a “monovalent JN.1-lineage vaccine composition.” The decision now moves to the FDA.

Novavax ( NVAX ) reportedly said it’s on track to deliver the recommended vaccine by September.

In a regulatory filing, the company also announced that the FDA recently notified Novavax ( NVAX ) that it completed its filing review of the final portion of the company's Biologics License Application (BLA) for its COVID-19 vaccine and has set a Prescription Drug User Fee Act (PDUFA) review goal date in April 2025 for the BLA.

As a result, Novavax ( NVAX ) expects the commercial sales of its COVID-19 vaccine in the U.S. during the 2024-2025 season to be under its existing Emergency Use Authorization.

See Also: Novavax Stock Rallies In Pre-Market As Company Plans To Deliver Covid-19 Vaccine By September

How To Buy NVAX

By now you're likely curious about how to participate in the market for Novavax ( NVAX ) – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. In the case of Novavax ( NVAX ), which is trading at $20.97 as of publishing time, $100 would buy you 4.77 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

NVAX Price Action: Novavax ( NVAX ) shares were up 13% at $23.70 at the time of publication, according to Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
IQVIA Holdings' Q4 Adjusted Earnings, Revenue Rise; 2025 Guidance Reaffirmed
IQVIA Holdings' Q4 Adjusted Earnings, Revenue Rise; 2025 Guidance Reaffirmed
Feb 6, 2025
07:25 AM EST, 02/06/2025 (MT Newswires) -- IQVIA Holdings ( IQV ) reported Q4 adjusted earnings Thursday of $3.12 per diluted share, up from $2.84 a year earlier. Analysts polled by FactSet expected $3.11. Revenue for the quarter ended Dec. 31 was $3.96 billion, compared with $3.87 billion a year earlier. Analysts surveyed by FactSet expected $3.93 billion. The company...
Carlsberg sees higher than expected 2025 growth, sending shares up
Carlsberg sees higher than expected 2025 growth, sending shares up
Feb 6, 2025
LONDON, Feb 6 (Reuters) - Carlsberg on Thursday reported annual operating profit growth at the top of its guided range and forecast higher than anticipated growth for 2025, sending the Danish brewer's shares 6% higher. Carlsberg, the world's third largest brewer behind Anheuser-Busch InBev and Heineken, said organic operating profit grew 6% for the full year, versus a guided range...
Thomson Reuters reports higher quarterly organic revenue
Thomson Reuters reports higher quarterly organic revenue
Feb 6, 2025
(Reuters) - Thomson Reuters ( TRI ) reported on Thursday higher fourth-quarter revenue and issued 2025 organic revenue growth targets that would exceed 2024 rates. The Toronto-based content and technology company reported quarterly revenue rising 5% to $1.909 billion, slightly ahead of analyst expectations of $1.907 billion, according to LSEG data. 2024 marked important progress at Thomson Reuters ( TRI...
Air Products beats estimates for quarterly profit amid costly boardroom battle
Air Products beats estimates for quarterly profit amid costly boardroom battle
Feb 6, 2025
Feb 6 (Reuters) - Industrial gases manufacturer Air Products beat Wall Street's expectations for first quarter profit on Thursday, as higher sales in key markets helped offset an expensive boardroom battle. The industrial gas giant, which produces helium and hydrogen, recently emerged from a months-long boardroom battle, absorbing a $29.9 million charge in the first quarter due to related costs....
Copyright 2023-2026 - www.financetom.com All Rights Reserved